8-K filing — Pulmonx Corp (LUNG)
Filed: 2026-10-27 AccNo: 0001127537-26-000042 Size: 363 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Pulmonx Reports Third Quarter 2026 Financial Results
Pulmonx Corporation reported its financial results for the third quarter ended September 30, 2026, highlighting a return to year-over-year revenue growth.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Tenon Medical (NASDAQ:TNON) shares moved upwards by 70.3% to $9.28 during Tuesday's after-market session. The market value of their outstanding shares is at $3.2 million. The company's, Q2 earnings came
Pulmonx shares are trading higher after the company reported better-than-expected Q2 financial results.